{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T12:54:46Z","timestamp":1769518486869,"version":"3.49.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T00:00:00Z","timestamp":1663804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Surg."],"abstract":"<jats:p>Machine perfusion (MP) has been shown worldwide to offer many advantages in liver transplantation, but it still has some gray areas. The purpose of the study is to evaluate the donor risk factors of grafts, perfused with any MP, that might predict an ineffective MP setting and those would trigger post-transplant early allograft dysfunction (EAD). Data from donors of all MP-perfused grafts at six liver transplant centers have been analyzed, whether implanted or discarded after perfusion. The first endpoint was the negative events after perfusion (NegE), which is the number of grafts discarded plus those that were implanted but lost after the transplant. A risk factor analysis for NegE was performed and marginal grafts for MP were identified. Finally, the risk of EAD was analyzed, considering only implanted grafts. From 2015 to September 2019, 158 grafts were perfused with MP: 151 grafts were implanted and 7 were discarded after the MP phase because they did not reach viability criteria. Of 151, 15 grafts were lost after transplant, so the NegE group consisted of 22 donors. In univariate analysis, the donor risk index &amp;gt;1.7, the presence of hypertension in the medical history, static cold ischemia time, and the moderate or severe macrovesicular steatosis were the significant factors for NegE. Multivariate analysis confirmed that macrosteatosis &amp;gt;30% was an independent risk factor for NegE (odd ratio 5.643, <jats:italic>p<\/jats:italic>\u2009=\u20090.023, 95% confidence interval, 1.27\u201324.98). Of 151 transplanted patients, 34% experienced EAD and had worse 1- and 3-year-survival, compared with those who did not face EAD (NoEAD), 96% and 96% for EAD vs. 89% and 71% for NoEAD, respectively (<jats:italic>p<\/jats:italic>\u2009=\u20090.03). None of the donor\/graft characteristics was associated with EAD even if the graft was moderately steatotic or fibrotic or from an aged donor. For the first time, this study shows that macrovesicular steatosis &amp;gt;30% might be a warning factor involved in the risk of graft loss or a cause of graft discard after the MP treatment. On the other hand, the MP seems to be useful in reducing the donor and graft weight in the development of EAD.<\/jats:p>","DOI":"10.3389\/fsurg.2022.975150","type":"journal-article","created":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T04:24:42Z","timestamp":1663820682000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["How useful is the machine perfusion in liver transplantation? An answer from a national survey"],"prefix":"10.3389","volume":"9","author":[{"given":"Irene","family":"Scalera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"De Carlis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Patrono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Gringeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Olivieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Pagano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Gruttadauria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Di Benedetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Cillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Romagnoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. G.","family":"Lupo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"De Carlis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/ajt.15674","article-title":"OPTN\/SRTR 2018 annual data report: liver","volume":"20","author":"Kwong","year":"2020","journal-title":"Am J Transplant"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1111\/tri.13358","article-title":"2018 annual report of the European liver transplant registry (ELTR)\u201450-year evolution\u00a0of liver transplantation","volume":"31","author":"Adam","year":"2018","journal-title":"Transpl Int"},{"key":"B3","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1053\/j.jvca.2014.02.017","article-title":"Hemodynamic recovery following postreperfusion syndrome in liver transplantation","volume":"28","author":"Fukazawa","year":"2014","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.3748\/wjg.v22.i4.1551","article-title":"Post reperfusion syndrome during liver transplantation: from pathophysiology to therapy and preventive strategies","volume":"22","author":"Siniscalchi","year":"2016","journal-title":"World J Gastroenterol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/liv.12443","article-title":"Donor information based prediction of early allograft dysfunction and outcome in liver transplantation","volume":"35","author":"Hoyer","year":"2015","journal-title":"Liver Int"},{"key":"B6","doi-asserted-by":"publisher","first-page":"9314","DOI":"10.3748\/wjg.v22.i42.9314","article-title":"Acute kidney injury and post-reperfusion syndrome in liver transplantation","volume":"22","author":"Umbro","year":"2016","journal-title":"World J Gastroenterol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/lt.21354","article-title":"Biliary complications following liver transplantation in the model for end-stage liver disease era: effect of donor, recipient, and technical factors","volume":"14","author":"Welling","year":"2008","journal-title":"Liver Transpl"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1080\/08941939.2018.1542048","article-title":"Using marginal grafts for liver transplantation: the balance of risk","author":"Kalisvaart","year":"","journal-title":"J Invest Surg"},{"key":"B9","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41586-018-0047-9","article-title":"A randomized trial of normothermic preservation in liver transplantation","volume":"557","author":"Nasralla","year":"2018","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/j.1600-6143.2006.01242.x","article-title":"Characteristics associated with liver graft failure: the concept of a donor risk index","volume":"6","author":"Feng","year":"2006","journal-title":"Am J Transplant"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1111\/j.1600-6143.2012.04195.x","article-title":"The Eurotransplant donor risk index in liver transplantation: ET-DRI","volume":"12","author":"Braat","year":"2012","journal-title":"Am J Transplant"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1111\/j.1600-6143.2008.02400.x","article-title":"Survival Outcomes Following Liver Transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation","volume":"8","author":"Rana","year":"2008","journal-title":"Am J Transplant"},{"key":"B13","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1097\/SLA.0b013e318272dea2","article-title":"The use of fatty liver grafts in modern allocation systems: risk assessment by the balance of risk (BAR) score","volume":"256","author":"Dutkowski","year":"2012","journal-title":"Ann Surg"},{"key":"B14","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1097\/00007890-199205000-00001","article-title":"Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies","volume":"53","author":"Clavien","year":"1992","journal-title":"Transplantation"},{"key":"B15","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/lt.21730","article-title":"Postreperfusion syndrome during liver transplantation for cirrhosis: outcome and predictors","volume":"15","author":"Paugam-Burtz","year":"2009","journal-title":"Liver Transpl"},{"key":"B16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.12659\/AOT.881861","article-title":"The occurrence of postreperfusion syndrome in orthotopic liver transplantation and its significance in terms of complications and short-term survival","volume":"16","author":"Bukowicka","year":"2011","journal-title":"Ann Transplant"},{"key":"B17","doi-asserted-by":"publisher","first-page":"6063","DOI":"10.1038\/s41598-020-62979-9","article-title":"Hypothermic oxygenated new machine perfusion system in liver and kidney transplantation of extended criteria donors: first Italian clinical trial","volume":"10","author":"Ravaioli","year":"2020","journal-title":"Sci Rep"},{"key":"B18","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jhep.2018.10.005","article-title":"Outcomes of DCD liver transplantation using organs treated by hypothermic oxygenated perfusion before implantation","volume":"70","author":"Schlegel","year":"2019","journal-title":"J Hepatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/lt.22091","article-title":"Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors","volume":"16","author":"Olthoff","year":"2010","journal-title":"Liver Transpl"},{"key":"B20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/00000658-199408000-00002","article-title":"Definition and classification of negative outcomes in solid organ transplantation. Application in liver transplantation","volume":"220","author":"Clavien","year":"1994","journal-title":"Ann Surg"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1002\/lt.25312","article-title":"Liver grafts from donors after circulatory death on regional perfusion with extended warm ischemia compared with donors after brain death","volume":"24","author":"De Carlis","year":"2018","journal-title":"Liver Transpl"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e13310","DOI":"10.1111\/ctr.13310","article-title":"Role of perfusion machines in the setting of clinical liver transplantation: a qualitative systematic review","volume":"32","author":"Lai","year":"2018","journal-title":"Clin Transplant"},{"key":"B23","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1097\/MOT.0000000000000303","article-title":"Hypothermic machine perfusion in liver transplantation","volume":"21","author":"Schlegel","year":"2016","journal-title":"Curr Opin Organ Transplant"},{"key":"B24","doi-asserted-by":"publisher","first-page":"172","DOI":"10.6002\/ect.2016.0347","article-title":"Hypothermic oxygenated machine perfusion for liver transplantation: an initial experience","volume":"16","author":"Patrono","year":"2018","journal-title":"Exp Clin Transplant"},{"key":"B25","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/lt.24666","article-title":"Successful donation after cardiac death liver transplants with prolonged warm ischemia time using normothermic regional perfusion","volume":"23","author":"De Carlis","year":"2017","journal-title":"Liver Transpl"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/lt.25817","article-title":"Machine perfusions in liver transplantation: the evidence-based position paper of the Italian society of organ and tissue transplantation","author":"Ghinolfi","year":"2020","journal-title":"Liver Transpl"},{"key":"B27","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/j.1440-1746.2011.06844.x","article-title":"Grade of deceased donor liver macrovesicular steatosis impacts graft and recipient outcomes more than the donor risk index","volume":"27","author":"de Graaf","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1097\/TP.0000000000000857","article-title":"Donor hepatic steatosis induce exacerbated ischemia-reperfusion injury through activation of innate immune response molecular pathways","volume":"99","author":"Gehrau","year":"2015","journal-title":"Transplantation"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1007\/s11605-015-2832-1","article-title":"Donor hepatic steatosis and outcome after liver transplantation: a systematic review","volume":"19","author":"Chu","year":"2015","journal-title":"J Gastrointest Surg"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1111\/ajt.14992","article-title":"Ex situ machine perfusion as a tool to recondition steatotic donor livers: troublesome features of fatty livers and the role of defatting therapies. A systematic review","volume":"18","author":"Boteon","year":"2018","journal-title":"Am J Transplant"},{"key":"B31","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/ajt.14583","article-title":"The first case of ischemia-free organ transplantation in humans: a proof of concept","volume":"18","author":"He","year":"2018","journal-title":"Am J Transplant"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s13304-020-00797-4","article-title":"Use of machine perfusion in livers showing steatosis prior to transplantation: a systematic review","author":"Lai","year":"2020","journal-title":"Updates Surg"},{"key":"B33","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.ymben.2009.05.005","article-title":"Metabolic preconditioning of donor organs: defatting fatty livers by normothermic perfusion ex vivo","volume":"11","author":"Nagrath","year":"2009","journal-title":"Metab Eng"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1002\/lt.24495","article-title":"Treatment with Optifast reduces hepatic steatosis and increases candidacy rates for living donor liver transplantation","volume":"22","author":"Doyle","year":"2016","journal-title":"Liver Transpl"},{"key":"B35","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1007\/s10620-015-3821-7","article-title":"Hepatocellular carcinoma in the setting of non-cirrhotic nonalcoholic fatty liver disease and the metabolic syndrome: US experience","volume":"60","author":"Perumpail","year":"2015","journal-title":"Dig Dis Sci"},{"key":"B36","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.cgh.2015.07.019","article-title":"Hepatocellular carcinoma in the absence of cirrhosis in United States veterans is associated with nonalcoholic fatty liver disease","volume":"14","author":"Mittal","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e223","DOI":"10.1097\/TP.0000000000001753","article-title":"Hypothermic machine perfusion of liver grafts can safely extend cold ischemia for up to 20 hours in cases of necessity","volume":"101","author":"De Carlis","year":"2017","journal-title":"Transplantation"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1002\/lt.24799","article-title":"The donor risk index: a decade of experience","volume":"23","author":"Flores","year":"2017","journal-title":"Liver Transpl"},{"key":"B39","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/lt.23990","article-title":"A score model for the continuous grading of early allograft dysfunction severity","volume":"21","author":"Pareja","year":"2015","journal-title":"Liver Transpl"},{"key":"B40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1590\/S1679-45082013000100006","article-title":"A proposal to grade the severity of early allograft dysfunction after liver transplantation","volume":"11","author":"Salvalaggio","year":"2013","journal-title":"Einstein (Sao Paulo)"}],"container-title":["Frontiers in Surgery"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2022.975150\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T04:24:43Z","timestamp":1663820683000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2022.975150\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,22]]},"references-count":40,"alternative-id":["10.3389\/fsurg.2022.975150"],"URL":"https:\/\/doi.org\/10.3389\/fsurg.2022.975150","relation":{},"ISSN":["2296-875X"],"issn-type":[{"value":"2296-875X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,22]]},"article-number":"975150"}}